A 67-year-old obese man with type 2 diabetes and established coronary artery disease has HbA₁c of 74 mmol/mol despite lifestyle measures. According to NICE NG28 and its 2025 update, what is the most appropriate first-line pharmacological strategy?AStart Metformin alone.BStart a sodium–glucose co-transporter 2 (SGLT2) inhibitor alone.CStart Metformin and consider early addition of an SGLT2 inhibitor because of cardiovascular disease.DStart a sulfonylurea such as Gliclazide alone.EStart insulin therapy immediately.Check my answer